Three Emerging Trends For China’s Pharmaceutical Foreign Trade

With the global economic slowdown, China's pharmaceutical foreign trade is likely to face its most difficult year yet since the beginning of the new century. In 2009, three development trends are emerging: (1) growth is expected to continue, with China maintaining its advantage and global market share in drug raw materials, especially antibiotics, vitamins, antipyretic analgesics and amino acids; (2) medical imports and exports will balance out health care reform resulting in increased domestic demand that will increase import volumes for major medical devices, technology, Western medicine and biomedicine, with high-end medical device import growth expected to hit double digits; and (3) many barriers will be encountered due to the rising yuan and intensifying trade war against China-made products. (Click here for more - Chinese Language)